. Author manuscript; available in PMC: 2015 Feb 1.

Published in final edited form as: Mol Genet Metab. 2013 Dec 11;111(2):101–106. doi: 10.1016/j.ymgme.2013.11.013

Table 4. Frequency of adverse events in hGH treated subjects.

	hGH treatment N =10	No hGH treatment N =13
Worsening ejection fraction?	0	2 (15)
Worsening/new obstructive sleep apnea?	1 (10)	1 (8)
Worsening/new intracranial hypertension?	1 (10)	0
Worsening/new kyphosis or scoliosis?	0	1 (8)
Slipped capital femoral epiphysis (SCFE)?	0	0
If taking GH – injection site reactions?	0	-
Development of diabetes?	0	0

N(%) with adverse event presented.

No significant differences by Fisher's exact test